Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2022 Volume 23 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2022 Volume 23 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article

miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1

  • Authors:
    • Yazhou Gao
    • Liming Wang
    • Zequn Niu
    • Hui Feng
    • Jie Liu
    • Jiangli Sun
    • Yanxia Gao
    • Longfei Pan
  • View Affiliations / Copyright

    Affiliations: Department of Emergency Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Emergency Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China
  • Article Number: 140
    |
    Published online on: December 14, 2021
       https://doi.org/10.3892/etm.2021.11063
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute pancreatitis (AP) is a common gastrointestinal disease that affects 1 million individuals worldwide. Inflammation and apoptosis are considered to be important pathogenic mechanisms of AP, and high mobility group box 1 (HMGB1) has been shown to play a particularly important role in the etiology of this disease. MicroRNAs (miRs) are emerging as critical regulators of gene expression and, as such, they represent a promising area of therapeutic target identification and development for a variety of diseases, including AP. Using the online database query (microRNA.org), the current study identified a site in the 3' untranslated region of HMGB1 mRNA that was a viable target for miR‑340‑5p. The present study aimed to investigate the association between miR‑340‑5p and HMGB1 expression in pancreatic acinar cells following lipopolysaccharide (LPS) treatment by performing luciferase, western blotting and reverse transcription‑quantitative PCR assays. The results suggest that miR‑340‑5p attenuates the induction of HMGB1 by LPS, thereby inhibiting inflammation and apoptosis via blunted activation of Toll‑like receptor 4 and enhanced AKT signaling. Thus, the therapeutic application of miR‑340‑5p may be a useful strategy in AP via upregulation of HMGB1 and subsequent promotion of inflammation and apoptosis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Ji L, Lv JC, Song ZF, Jiang MT, Li L and Sun B: Risk factors of infected pancreatic necrosis secondary to severe acute pancreatitis. Hepatobiliary Pancreat Dis Int. 15:428–433. 2016.PubMed/NCBI View Article : Google Scholar

2 

Singh P and Garg PK: Pathophysiological mechanisms in acute pancreatitis: Current understanding. Indian J Gastroenterol. 35:153–166. 2016.PubMed/NCBI View Article : Google Scholar

3 

Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P and Chevali L: Pathophysiology of acute pancreatitis. Pancreatology. 5:132–144. 2005.PubMed/NCBI View Article : Google Scholar

4 

Pandol SJ, Saluja AK, Imrie CW and Banks PA: Acute pancreatitis: Bench to the bedside. Gastroenterology. 132:1127–1151. 2007.PubMed/NCBI View Article : Google Scholar

5 

Jiang J, Yamato E and Miyazaki J: Intravenous delivery of naked plasmid DNA for in vivo cytokine expression. Biochem Biophys Res Commun. 289:1088–1092. 2001.PubMed/NCBI View Article : Google Scholar

6 

Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J, Ono M, Takeshita F, Niida S, Shimizu C, et al: Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 107:326–334. 2016.PubMed/NCBI View Article : Google Scholar

7 

Cech TR and Steitz JA: The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 157:77–94. 2014.PubMed/NCBI View Article : Google Scholar

8 

Khoshnam SE, Winlow W, Farbood Y, Moghaddam HF and Farzaneh M: Emerging roles of microRNAs in ischemic stroke: As possible therapeutic agents. J Stroke. 19:166–187. 2017.PubMed/NCBI View Article : Google Scholar

9 

Malumbres M: miRNAs and cancer: An epigenetics view. Mol Aspects Med. 34:863–874. 2013.PubMed/NCBI View Article : Google Scholar

10 

Matts J, Jagadeeswaran G, Roe BA and Sunkar R: Identification of microRNAs and their targets in switchgrass, a model biofuel plant species. J Plant Physiol. 167:896–904. 2010.PubMed/NCBI View Article : Google Scholar

11 

Qu B and Shen N: miRNAs in the pathogenesis of systemic lupus erythematosus. Int J Mol Sci. 16:9557–9572. 2015.PubMed/NCBI View Article : Google Scholar

12 

Wang W, Dai LX, Zhang S, Yang Y, Yan N, Fan P, Dai L, Tian HW, Cheng L, Zhang XM, et al: Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo. Neoplasma. 60:274–283. 2013.PubMed/NCBI View Article : Google Scholar

13 

Liu Y, Gao Y, Yang J, Shi C, Wang Y and Xu Y: MicroRNA-381 reduces inflammation and infiltration of macrophages in polymyositis via downregulating HMGB1. Int J Oncol. 53:1332–1342. 2018.PubMed/NCBI View Article : Google Scholar

14 

Wei D, Miao Y, Yu L, Wang D and Wang Y: Downregulation of microRNA-198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN. Mol Med Rep. 18:595–602. 2018.PubMed/NCBI View Article : Google Scholar

15 

Zhang J, Ning X, Cui W, Bi M, Zhang D and Zhang J: Transforming growth factor (TGF)-β-induced microRNA-216a promotes acute pancreatitis via Akt and TGF-β pathway in mice. Dig Dis Sci. 60:127–135. 2015.PubMed/NCBI View Article : Google Scholar

16 

Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, et al: Epidemiology of sepsis in Germany: Results from a national prospective multicenter study. Intensive Care Med. 33:606–618. 2007.PubMed/NCBI View Article : Google Scholar

17 

Wu H, Li R, Pei LG, Wei ZH, Kang LN, Wang L, Xie J and Xu B: Emerging role of high mobility group box-1 in thrombosis-related diseases. Cell Physiol Biochem. 47:1319–1337. 2018.PubMed/NCBI View Article : Google Scholar

18 

Gao N, Yan C and Zhang G: Changes of serum procalcitonin (PCT), C-reactive protein (CRP), interleukin-17 (IL-17), interleukin-6 (IL-6), high mobility group protein-B1 (HMGB1) and D-dimer in patients with severe acute pancreatitis treated with continuous renal replacement therapy (CRRT) and its clinical significance. Med Sci Monit. 24:5881–5886. 2018.PubMed/NCBI View Article : Google Scholar

19 

Zhao S, Yang J, Liu T, Zeng J, Mi L and Xiang K: Dexamethasone inhibits NF-κBp65 and HMGB1 expression in the pancreas of rats with severe acute pancreatitis. Mol Med Rep. 18:5345–5352. 2018.PubMed/NCBI View Article : Google Scholar

20 

Kang R, Zhang Q, Hou W, Yan Z, Chen R, Bonaroti J, Bansal P, Billiar TR, Tsung A, Wang Q, et al: Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology. 146:1097–1107. 2014.PubMed/NCBI View Article : Google Scholar

21 

Zhang ZW, Zhang QY, Zhou MT, Liu NX, Chen TK, Zhu YF and Wu L: Antioxidant inhibits HMGB1 expression and reduces pancreas injury in rats with severe acute pancreatitis. Dig Dis Sci. 55:2529–2536. 2010.PubMed/NCBI View Article : Google Scholar

22 

Kang R, Lotze MT, Zeh HJ, Billiar TR and Tang D: Cell death and DAMPs in acute pancreatitis. Mol Med. 20:466–477. 2014.PubMed/NCBI View Article : Google Scholar

23 

Saluja A, Dudeja V, Dawra R and Sah RP: Early intra-acinar events in pathogenesis of pancreatitis. Gastroenterology. 156:1979–1993. 2019.PubMed/NCBI View Article : Google Scholar

24 

Cheng L, Luo Z, Xiang K, Ren J, Huang Z, Tang L and Tian F: Clinical significance of serum triglyceride elevation at early stage of acute biliary pancreatitis. BMC Gastroenterol. 15(19)2015.PubMed/NCBI View Article : Google Scholar

25 

Sit M, Aktas G, Yilmaz EE, Alcelik A, Terzi EH and Tosun M: Effects of the inflammatory response on serum omentin levels in early acute and chronic pancreatitis. Clin Ter. 165:e148–e152. 2014.PubMed/NCBI View Article : Google Scholar

26 

Schneider L, Jabrailova B, Strobel O, Hackert T and Werner J: Inflammatory profiling of early experimental necrotizing pancreatitis. Life Sci. 126:76–80. 2015.PubMed/NCBI View Article : Google Scholar

27 

Yang R, Tenhunen J and Tonnessen TI: HMGB1 and histones play a significant role in inducing systemic inflammation and multiple organ dysfunctions in severe acute pancreatitis. Int J Inflam. 2017(1817564)2017.PubMed/NCBI View Article : Google Scholar

28 

Habtezion A: Inflammation in acute and chronic pancreatitis. Curr Opin Gastroenterol. 31:395–399. 2015.PubMed/NCBI View Article : Google Scholar

29 

Wang S, Ni HM, Chao X, Wang H, Bridges B, Kumer S, Schmitt T, Mareninova O, Gukovskaya A, De Lisle RC, et al: Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis. Autophagy. 15:1954–1969. 2019.PubMed/NCBI View Article : Google Scholar

30 

Xin-Peng Z, Yong-Hua H, Yong L, Jing-Jing W, Guang-Hua W, Ren-Jie W and Min Z: A high-mobility group box 1 that binds to DNA, enhances pro-inflammatory activity, and acts as an anti-infection molecule in black rockfish, Sebastes schlegelii. Fish Shellfish Immunol. 56:402–409. 2016.PubMed/NCBI View Article : Google Scholar

31 

Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszyński A, et al: Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science. 341:1246–1249. 2013.PubMed/NCBI View Article : Google Scholar

32 

Keppler-Noreuil KM, Parker VE, Darling TN and Martinez-Agosto JA: Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C Semin Med Genet. 172:402–421. 2016.PubMed/NCBI View Article : Google Scholar

33 

Estaras M, Ameur FZ, Roncero V, Fernandez-Bermejo M, Blanco G, Lopez D, Mateos JM, Salido GM and Gonzalez A: The melatonin receptor antagonist luzindole induces Ca2+ mobilization, reactive oxygen species generation and impairs trypsin secretion in mouse pancreatic acinar cells. Biochim Biophys Acta Gen Subj. 1863(129407)2019.PubMed/NCBI View Article : Google Scholar

34 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

35 

Zhao Q, Zhang H, Wu J, Lv X, Jin X and Hu J: Melatonin inhibits the endoplasmic reticulum stress-induced, C/EBP homologous protein-mediated pathway in acute pancreatitis. Mol Med Rep. 22:1647–1655. 2020.PubMed/NCBI View Article : Google Scholar

36 

Liu Y, Yang L, Chen KL, Zhou B, Yan H, Zhou ZG and Li Y: Knockdown of GRP78 promotes apoptosis in pancreatic acinar cells and attenuates the severity of cerulein and LPS induced pancreatic inflammation. PLoS One. 9(e92389)2014.PubMed/NCBI View Article : Google Scholar

37 

Li Z, Xu C, Tao Y, Liang Y, Liang Q, Li J, Li R and Ye H: Anisodamine alleviates lipopolysaccharide-induced pancreatic acinar cell injury through NLRP3 inflammasome and NF-κB signaling pathway. J Recept Signal Transduct Res. 40:58–66. 2020.PubMed/NCBI View Article : Google Scholar

38 

Zhang H, Li YY and Wu XZ: Effect of Tetrandrine on LPS-induced NF-kappaB activation in isolated pancreatic acinar cells of rat. World J Gastroenterol. 12:4232–4236. 2006.PubMed/NCBI View Article : Google Scholar

39 

Bhatia M: Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy. 1:343–351. 2002.PubMed/NCBI View Article : Google Scholar

40 

Petrov MS, Shanbhag S, Chakraborty M, Phillips AR and Windsor JA: Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 139:813–820. 2010.PubMed/NCBI View Article : Google Scholar

41 

Hong YP, Yu J, Su YR, Mei FC, Li M, Zhao KL, Zhao L, Deng WH, Chen C and Wang WX: High-fat diet aggravates acute pancreatitis via TLR4-mediated necroptosis and inflammation in rats. Oxid Med Cell Longev. 2020(8172714)2020.PubMed/NCBI View Article : Google Scholar

42 

Zhang X, Zhu C, Wu D and Jiang X: Possible role of toll-like receptor 4 in acute pancreatitis. Pancreas. 39:819–824. 2010.PubMed/NCBI View Article : Google Scholar

43 

Abliz A, Deng W, Sun R, Guo W, Zhao L and Wang W: Wortmannin, PI3K/Akt signaling pathway inhibitor, attenuates thyroid injury associated with severe acute pancreatitis in rats. Int J Clin Exp Pathol. 8:13821–13833. 2015.PubMed/NCBI

44 

Xu P, Wang J, Yang ZW, Lou XL and Chen C: Regulatory roles of the PI3K/Akt signaling pathway in rats with severe acute pancreatitis. PLoS One. 8(e81767)2013.PubMed/NCBI View Article : Google Scholar

45 

Liu Y, Liao R, Qiang Z and Zhang C: Pro-inflammatory cytokine-driven PI3K/Akt/Sp1 signalling and H2S production facilitates the pathogenesis of severe acute pancreatitis. Biosci Rep. 37(BSR20160483)2017.PubMed/NCBI View Article : Google Scholar

46 

Fan J, Li Y, Levy RM, Fan JJ, Hackam DJ, Vodovotz Y, Yang H, Tracey KJ, Billiar TR and Wilson MA: Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: Role of HMGB1-TLR4 signaling. J Immunol. 178:6573–6580. 2007.PubMed/NCBI View Article : Google Scholar

47 

Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, Nawroth P, Andersson U, Harris RA and Harris HE: RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol. 61:1–9. 2005.PubMed/NCBI View Article : Google Scholar

48 

Tian X, Sun L, Feng D, Sun Q, Dou Y, Liu C, Zhou F, Li H, Shen H, Wang Z and Chen G: HMGB1 promotes neurovascular remodeling via Rage in the late phase of subarachnoid hemorrhage. Brain Res. 1670:135–145. 2017.PubMed/NCBI View Article : Google Scholar

49 

Akira S, Takeda K and Kaisho T: Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol. 2:675–680. 2001.PubMed/NCBI View Article : Google Scholar

50 

Xu GF, Guo M, Tian ZQ, Wu GZ, Zou XP and Zhang WJ: Increased of serum high-mobility group box chromosomal protein 1 correlated with intestinal mucosal barrier injury in patients with severe acute pancreatitis. World J Emerg Surg. 9(61)2014.PubMed/NCBI View Article : Google Scholar

51 

Kylänpää ML, Repo H and Puolakkainen PA: Inflammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol. 16:2867–2872. 2010.PubMed/NCBI View Article : Google Scholar

52 

Sun J, Shi S, Wang Q, Yu K and Wang R: Continuous hemodiafiltration therapy reduces damage of multi-organs by ameliorating of HMGB1/TLR4/NFκB in a dog sepsis model. Int J Clin Exp Pathol. 8:1555–1564. 2015.PubMed/NCBI

53 

Todorova J and Pasheva E: High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues. Oncol Lett. 3:214–218. 2012.PubMed/NCBI View Article : Google Scholar

54 

Schiraldi M, Raucci A, Muñoz LM, Livoti E, Celona B, Venereau E, Apuzzo T, De Marchis F, Pedotti M, Bachi A, et al: HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med. 209:551–563. 2012.PubMed/NCBI View Article : Google Scholar

55 

Diener KR, Al-Dasooqi N, Lousberg EL and Hayball JD: The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer. Immunol Cell Biol. 91:443–450. 2013.PubMed/NCBI View Article : Google Scholar

56 

Biscetti F, Ghirlanda G and Flex A: Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration. Curr Vasc Pharmacol. 9:677–681. 2011.PubMed/NCBI View Article : Google Scholar

57 

Kanakoudi-Tsakalidou F, Farmaki E, Tzimouli V, Taparkou A, Paterakis G, Trachana M, Pratsidou-Gertsi P, Nalbanti P and Papachristou F: Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options? Lupus. 23:305–312. 2014.PubMed/NCBI View Article : Google Scholar

58 

Gu H, Werner J, Bergmann F, Whitcomb DC, Büchler MW and Fortunato F: Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis. Cell Death Dis. 4(e816)2013.PubMed/NCBI View Article : Google Scholar

59 

Samanta S, Balasubramanian S, Rajasingh S, Patel U, Dhanasekaran A, Dawn B and Rajasingh J: MicroRNA: A new therapeutic strategy for cardiovascular diseases. Trends Cardiovasc Med. 26:407–419. 2016.PubMed/NCBI View Article : Google Scholar

60 

Wang AY, Ehrhardt A, Xu H and Kay MA: Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver. Mol Ther. 15:255–263. 2007.PubMed/NCBI View Article : Google Scholar

61 

Wang AY, Peng PD, Ehrhardt A, Storm TA and Kay MA: Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo. Hum Gene Ther. 15:405–413. 2004.PubMed/NCBI View Article : Google Scholar

62 

Li D, Zhou J, Yang B and Yu Y: MicroRNA-340-5p inhibits hypoxia/reoxygenation-induced apoptosis and oxidative stress in cardiomyocytes by regulating the Act1/NF-κB pathway. J Cell Biochem. 120:14618–14627. 2019.PubMed/NCBI View Article : Google Scholar

63 

Zheng Y, Zhao P, Lian Y, Li S, Chen Y and Li L: MiR-340-5p alleviates oxygen-glucose deprivation/reoxygenation-induced neuronal injury via PI3K/Akt activation by targeting PDCD4. Neurochem Int. 134(104650)2020.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gao Y, Wang L, Niu Z, Feng H, Liu J, Sun J, Gao Y and Pan L: miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1. Exp Ther Med 23: 140, 2022.
APA
Gao, Y., Wang, L., Niu, Z., Feng, H., Liu, J., Sun, J. ... Pan, L. (2022). miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1. Experimental and Therapeutic Medicine, 23, 140. https://doi.org/10.3892/etm.2021.11063
MLA
Gao, Y., Wang, L., Niu, Z., Feng, H., Liu, J., Sun, J., Gao, Y., Pan, L."miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1". Experimental and Therapeutic Medicine 23.2 (2022): 140.
Chicago
Gao, Y., Wang, L., Niu, Z., Feng, H., Liu, J., Sun, J., Gao, Y., Pan, L."miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1". Experimental and Therapeutic Medicine 23, no. 2 (2022): 140. https://doi.org/10.3892/etm.2021.11063
Copy and paste a formatted citation
x
Spandidos Publications style
Gao Y, Wang L, Niu Z, Feng H, Liu J, Sun J, Gao Y and Pan L: miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1. Exp Ther Med 23: 140, 2022.
APA
Gao, Y., Wang, L., Niu, Z., Feng, H., Liu, J., Sun, J. ... Pan, L. (2022). miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1. Experimental and Therapeutic Medicine, 23, 140. https://doi.org/10.3892/etm.2021.11063
MLA
Gao, Y., Wang, L., Niu, Z., Feng, H., Liu, J., Sun, J., Gao, Y., Pan, L."miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1". Experimental and Therapeutic Medicine 23.2 (2022): 140.
Chicago
Gao, Y., Wang, L., Niu, Z., Feng, H., Liu, J., Sun, J., Gao, Y., Pan, L."miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1". Experimental and Therapeutic Medicine 23, no. 2 (2022): 140. https://doi.org/10.3892/etm.2021.11063
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team